PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTS
Abstract
Authors
J. Menzin C. Duczakowski M. Friedman P. Neumann R. Scranton